The University of Chicago Header Logo

Connection

Richard Schilsky to Receptor, ErbB-3

Back to Details
This is a "connection" page, showing publications Richard Schilsky has written about Receptor, ErbB-3.
Richard Schilsky
Connection Strength
0.841
Receptor, ErbB-3
  1. Pertuzumab Plus Trastuzumab in Patients With Biliary Tract Cancer With ERBB2/3 Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study. J Clin Oncol. 2024 Sep 20; 42(27):3228-3237.
    View in: PubMed
    Score: 0.841
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.